documents: FDA-2023-E-3236-0006
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2023-E-3236-0006 | FDA | FDA-2023-E-3236 | Determination of Regulatory Review Period for Purposes of Patent Extension; LEQEMBI | Notice | Determinations | 2025-12-29T05:00:00Z | 2025 | 12 | 2025-12-29T05:00:00Z | 2026-02-28T04:59:59Z | 2025-12-29T20:09:09Z | 2025-23865 | 0 | 0 | 09000064b910a288 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref